Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence and risk factors for venous and arterial thromboses in hospitalized patients with coronavirus disease 2019: data on 4014 patients from a tertiary center registry.
Jurin I, Lucijanić M, Piskač Živković N, Lalić K, Zrilić Vrkljan A, Malnar Janeš L, Kovačević I, Čikara T, Sabljić A, Bušić N, Vukorepa G, Hadžibegović I, Lukšić I, Baršić B. Jurin I, et al. Among authors: sabljic a. Croat Med J. 2022 Feb 28;63(1):16-26. doi: 10.3325/cmj.2022.63.16. Croat Med J. 2022. PMID: 35230002 Free PMC article.
Gradual increase in red cell distribution width is similarly prognostic for in-hospital mortality in both anemic and non-anemic COVID-19 patients.
Lucijanic M, Soric E, Sedinic Lacko M, Sabljic A, Krecak I, Bistrovic P, Jordan A, Manola S, Jaksic O, Lucijanic T, Derek L, Kusec R. Lucijanic M, et al. Among authors: sabljic a. J Med Virol. 2022 Aug;94(8):3509-3511. doi: 10.1002/jmv.27785. Epub 2022 Apr 21. J Med Virol. 2022. PMID: 35419812 Free PMC article. No abstract available.
Comparison of IMPROVE, modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC risk scores for venous and arterial thrombotic events prediction in hospitalized COVID-19 patients.
Lucijanic M, Jurin I, Sedinic Lacko M, Soric E, Sabljic A, Krecak I, Mitrovic J, Marelic D, Kremer Z, Hadzibegovic I, Lucijanic T, Kusec R. Lucijanic M, et al. Among authors: sabljic a. Thromb Res. 2022 Jun;214:37-39. doi: 10.1016/j.thromres.2022.04.009. Epub 2022 Apr 18. Thromb Res. 2022. PMID: 35461036 Free PMC article. No abstract available.
Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis.
Lucijanic M, Krecak I, Soric E, Sabljic A, Galusic D, Holik H, Perisa V, Moric Peric M, Zekanovic I, Kusec R. Lucijanic M, et al. Among authors: sabljic a. Leuk Res. 2022 Aug;119:106905. doi: 10.1016/j.leukres.2022.106905. Epub 2022 Jun 21. Leuk Res. 2022. PMID: 35759912 No abstract available.
Risks associated with prior oral anticoagulation use in hospitalized COVID-19 patients - A retrospective cohort study on 5392 patients from a tertiary centre.
Bistrovic P, Sabljic A, Kovacevic I, Cikara T, Keres T, Lucijanic T, Mitrovic J, Delic-Brkljacic D, Manola S, Lucijanic M. Bistrovic P, et al. Among authors: sabljic a. Int J Cardiol. 2023 Feb 1;372:144-149. doi: 10.1016/j.ijcard.2022.11.051. Epub 2022 Nov 28. Int J Cardiol. 2023. PMID: 36471534 Free PMC article.
Clinical presentation, treatment patterns, and outcomes of pulmonary embolism in patients with chronic myeloproliferative neoplasms.
Krečak I, Grohovac D, Vučenović Bašić N, Čeko M, Nižetić K, Sabljić A, Holik H, Galušić D, Zekanović I, Morić Perić M, Periša V, Lucijanić M. Krečak I, et al. Among authors: sabljic a. Thromb Res. 2023 Nov;231:141-143. doi: 10.1016/j.thromres.2023.03.004. Epub 2023 Mar 21. Thromb Res. 2023. PMID: 36964024 No abstract available.
61 results